Clinical pharmacology study to investigate the food effect on pharmacokinetics of TAS-102.
Phase 1
- Conditions
- Patients with solid tumor
- Registration Number
- JPRN-jRCT2080221443
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
1) Signed, written informed consent.
2) Histologically or cytologically confirmed solid tumor.
3) Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
Exclusion Criteria
1) Patients with gastric cancer or stomach excised
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics
- Secondary Outcome Measures
Name Time Method Safety, Efficacy<br>CTCAE (ver.4.0), RECIST (ver.1.1)